196 related articles for article (PubMed ID: 28641043)
21. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography.
Zhang J; Mironov S; Hricak H; Ishill NM; Moskowitz CS; Soslow RA; Chi DS
J Comput Assist Tomogr; 2008; 32(4):533-40. PubMed ID: 18664838
[TBL] [Abstract][Full Text] [Related]
22. Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months.
Rizzo S; Botta F; Raimondi S; Origgi D; Buscarino V; Colarieti A; Tomao F; Aletti G; Zanagnolo V; Del Grande M; Colombo N; Bellomi M
Eur Radiol; 2018 Nov; 28(11):4849-4859. PubMed ID: 29737390
[TBL] [Abstract][Full Text] [Related]
23. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
Diaz-Gil D; Fintelmann FJ; Molaei S; Elmi A; Hedgire SS; Harisinghani MG
Abdom Radiol (NY); 2016 Nov; 41(11):2196-2202. PubMed ID: 27338731
[TBL] [Abstract][Full Text] [Related]
24. Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.
Mironov O; Sala E; Mironov S; Pannu H; Chi DS; Hricak H
J Gynecol Oncol; 2011 Dec; 22(4):260-8. PubMed ID: 22247803
[TBL] [Abstract][Full Text] [Related]
25. Predicting Neoadjuvant Chemotherapy Response and High-Grade Serous Ovarian Cancer From CT Images in Ovarian Cancer with Multitask Deep Learning: A Multicenter Study.
Yin R; Guo Y; Wang Y; Zhang Q; Dou Z; Wang Y; Qi L; Chen Y; Zhang C; Li H; Jian X; Ma W
Acad Radiol; 2023 Sep; 30 Suppl 2():S192-S201. PubMed ID: 37336707
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Murakami R; Matsumura N; Mandai M; Yoshihara K; Tanabe H; Nakai H; Yamanoi K; Abiko K; Yoshioka Y; Hamanishi J; Yamaguchi K; Baba T; Koshiyama M; Enomoto T; Okamoto A; Murphy SK; Mori S; Mikami Y; Minamiguchi S; Konishi I
Am J Pathol; 2016 May; 186(5):1103-13. PubMed ID: 26993207
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
Michielsen K; Dresen R; Vanslembrouck R; De Keyzer F; Amant F; Mussen E; Leunen K; Berteloot P; Moerman P; Vergote I; Vandecaveye V
Eur J Cancer; 2017 Sep; 83():88-98. PubMed ID: 28734146
[TBL] [Abstract][Full Text] [Related]
28. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.
Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
Gynecol Oncol; 2008 Feb; 108(2):265-70. PubMed ID: 18055006
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
[TBL] [Abstract][Full Text] [Related]
30. Ovarian Cancer: An Evidence-Based, Easy-to-Use Prediction Rule to Optimize the Use of Follow-up Chest CT.
Shinagare AB; Suh CH; Kim KW; Somarouthu B; Van den Abbeele AD; Ramaiya NH
J Am Coll Radiol; 2017 Apr; 14(4):499-508. PubMed ID: 27720583
[TBL] [Abstract][Full Text] [Related]
31. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
[TBL] [Abstract][Full Text] [Related]
32. CT Differentiation of Female Peritoneal Tuberculosis and Peritoneal Carcinomatosis From Normal-Sized Ovarian Cancer.
Shim SW; Shin SH; Kwon WJ; Jeong YK; Lee JH
J Comput Assist Tomogr; 2017 Jan; 41(1):32-38. PubMed ID: 27636249
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer.
Fujwara K; Yoshino K; Enomoto T; Fujita M; Ueda Y; Miyatake T; Kimura T; Muraji M; Fujita H; Kimura T; Hori M
Arch Gynecol Obstet; 2011 Dec; 284(6):1501-7. PubMed ID: 21347681
[TBL] [Abstract][Full Text] [Related]
34. A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.
Vargas HA; Veeraraghavan H; Micco M; Nougaret S; Lakhman Y; Meier AA; Sosa R; Soslow RA; Levine DA; Weigelt B; Aghajanian C; Hricak H; Deasy J; Snyder A; Sala E
Eur Radiol; 2017 Sep; 27(9):3991-4001. PubMed ID: 28289945
[TBL] [Abstract][Full Text] [Related]
35. Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.
Ganeshan D; Bhosale P; Wei W; Ramalingam P; Mudasiru-Dawodu E; Gershenson D; Sun C; Iyer R
Abdom Radiol (NY); 2016 Aug; 41(8):1589-95. PubMed ID: 26969496
[TBL] [Abstract][Full Text] [Related]
36. Histopathological subtyping of high-grade serous ovarian cancer using whole slide imaging.
Miyagawa C; Nakai H; Otani T; Murakami R; Takamura S; Takaya H; Murakami K; Mandai M; Matsumura N
J Gynecol Oncol; 2023 Jul; 34(4):e47. PubMed ID: 36807749
[TBL] [Abstract][Full Text] [Related]
37. Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread.
Bachmayr-Heyda A; Auer K; Sukhbaatar N; Aust S; Deycmar S; Reiner AT; Polterauer S; Dekan S; Pils D
Oncotarget; 2016 Jun; 7(26):39640-39653. PubMed ID: 27172797
[TBL] [Abstract][Full Text] [Related]
38. Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.
Burger IA; Goldman DA; Vargas HA; Kattan MW; Yu C; Kou L; Andikyan V; Chi DS; Hricak H; Sala E
Gynecol Oncol; 2015 Sep; 138(3):554-9. PubMed ID: 26093061
[TBL] [Abstract][Full Text] [Related]
39. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer.
Coakley FV; Choi PH; Gougoutas CA; Pothuri B; Venkatraman E; Chi D; Bergman A; Hricak H
Radiology; 2002 May; 223(2):495-9. PubMed ID: 11997559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
